MATINAS BIOPHARMA HOLDINGS, INC. Proceeds from Long-term Capital Lease Obligations
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Proceeds from Long-term Capital Lease Obligations of $19.04 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermCapitalLeaseObligations · last filed 2016-08-15
- 2016-06-30: Proceeds from Long-term Capital Lease Obligations 6 month $19.04K.
- 2015-06-30: Proceeds from Long-term Capital Lease Obligations 6 month $0.00.
| Period end | Proceeds from Long-term Capital Lease Obligations 6 month |
|---|---|
| 2016-06-30 | $19.04K 10-Q · filed 2016-08-15 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |